Patent application number | Description | Published |
20090036709 | METHOD FOR PRODUCING 5-AMINOLEVULINIC ACID HYDROCHLORIDE - A method for producing crystals of 5-aminolevulinic acid hydrochloride wherein, in carrying out adsorption of 5-aminolevulinic acid contained in a crude 5-aminolevulinic acid solution by a cation exchange resin and its subsequent desorption with an aqueous solution containing ammonium ion, a high purity 5-aminolevulinic acid aqueous solution is obtained using a change in electric conductivity or pH of the desorption liquid as the index, and chloride ion is added to the aqueous solution which is then mixed with an organic solvent. | 02-05-2009 |
20100035754 | AGENT FOR IMPROVING ALKALI RESISTANCE OF PLANT AND METHOD FOR IMPROVING ALKALI RESISTANCE OF PLANT - The present invention is directed to an agent for improving alkali tolerance of a plant and to a method for improving alkali tolerance of a plant through application of the agent to the plant. | 02-11-2010 |
20100105948 | HOP ALPHA ACID OR HOP OIL CONTENT ENHANCER - To provide a hop alpha acid or hop oil content enhancer, which increases the content of a hop alpha acid or a hop oil. | 04-29-2010 |
20100120916 | THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASES - To provide a therapeutic agent and a diagnostic agent for mitochondrial dysfunction brain diseases including cerebral infarction as a representative. | 05-13-2010 |
20100173780 | POLYPHENOL-CONTENT-INCREASING AGENT FOR PLANT - To provide a polyphenol-content-increasing agent which increases the content of polyphenol in a plant. A polyphenol-content-increasing agent for plant, containing, as an active ingredient, a 5-aminolevulinic acid or a derivative thereof represented by the following formula (1): | 07-08-2010 |
20110065787 | THERAPEUTIC AGENT FOR MALE STERILITY - The present invention is intended to provide an agent for treating male infertility which is highly effective to male infertility, and having few side effects. To achieve the object, an agent for treating male infertility comprising δ-amino levulinic acid shown by general formula (1), its derivative or salt thereof: | 03-17-2011 |
20110244110 | HOP ALPHA ACID OR HOP OIL CONTENT ENHANCER - A hop alpha acid or hop oil content enhancer, which contains 5-aminolevulinic acid, or a derivative thereof represented by the following formula (1), or a salt thereof as an active ingredient: | 10-06-2011 |
20120172227 | 5-AMINOLEVULINIC ACID SALT, PROCESS FOR PRODUCING THE SAME AND USE THEREOF - A 5-aminolevulinic acid salt which is useful in fields of microorganisms, fermentation, animals, medicaments, plants and the like; a process for producing the same; a medical composition comprising the same; and a plant activator composition comprising the same. | 07-05-2012 |
20130011337 | THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASES - To provide a therapeutic agent and a diagnostic agent for mitochondrial dysfunction brain diseases including cerebral infarction as a representative. | 01-10-2013 |
20130095520 | METHOD FOR DETECTION OF UROTHELIAL CANCER - It is to provide a method for detecting urothelial cancer simply and with high accuracy. It is a method for detecting urothelial cancer comprising administering 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of these to a test subject, collecting urine from the test subject, and detecting the presence of fluorescence or amount of fluorescence in the collected urine. | 04-18-2013 |
20130108710 | Antimalarial Drug Which Contains 5-Aminolevulinic Acid or Derivative Thereof as Active Ingredient | 05-02-2013 |
20130158293 | CANCER HEAT THERAPY-ENHANCING AGENT - Provided is an enhancer for cancer thermotherapy not combined with photodynamic therapy. Cancer treatment not combined with photodynamic therapy is made available by using, as an enhancer for cancer thermotherapy, 5-aminolevulinic acids represented by formula (1): | 06-20-2013 |
20130217913 | Antimalarial Drug Comprising Alaremycin or Derivative Thereof as Active Ingredient - Provided is a preventive and/or therapeutic agent for malaria, comprising, as an active ingredient, 5-acetamido-4-oxo-5-hexenoic acid (Alaremycin) or a derivative thereof. A preventive and/or therapeutic agent for malaria is used which comprises, as an active ingredient, Alaremycin or a derivative thereof represented by formula (I) (wherein R | 08-22-2013 |
20140219590 | RADIAL FOIL BEARING - This relates to a radial foil bearing ( | 08-07-2014 |
20140256806 | PROPHYLACTIC AGENT FOR CHRONIC KIDNEY DISEASE - A method for ameliorating and/or preventing chronic kidney disease includes administering to a subject in need thereof an agent containing 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt thereof as an active ingredient. Preferably, these ALAs contain a metal-containing compound, such as sodium ferrous citrate. The above-mentioned ALAs, ALA; various esters, such as ALA methylester, ALA ethylester, ALA propylester, ALA butylester, and ALA pentylester; and hydrochlorides, phosphates, and sulfates, and the like of these ALA esters are preferred examples. | 09-11-2014 |
20140288172 | ERYTHROPOIETIN PRODUCTION-PROMOTING AGENT - A therapeutic and/or prophylactic agent for renal anemia comprising ALAs and an erythropoietin production promoter comprising ALAs. | 09-25-2014 |
20140288173 | ANEMIA OF CANCER IMPROVING/PROPHYLACTIC AGENT - A method for ameliorating and/or preventing cancerous anemia includes administering to a subject in need thereof an agent containing 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt thereof. Preferably, these ALAs contain a metal-containing compound, such as sodium ferrous citrate. The above-mentioned ALAs, ALA; various esters such as ALA methylester, ALA ethylester, ALA propylester, ALA butylester, and ALA pentylester; and hydrochlorides, phosphates, and sulfates, and the like of these ALA esters are preferred examples. | 09-25-2014 |
20140302173 | TREATMENT AGENT AND/OR PROPHYLACTIC AGENT FOR SIDE EFFECTS OF CANCER DRUGS - A method for treating side effects of anticancer agent includes administering to a subject in need thereof a prophylactic and/or therapeutic agent containing a therapeutically effective amount of a compound shown by the following Formula (1): | 10-09-2014 |
20140343140 | Agent for Preventing and/or Treating Veisalgia - [Problem] To provide an agent for preventing and/or treating veisalgia. [Solution] Provided is an agent for preventing and/or treating veisalgia, the agent including an ALA (5-aminolevulinic acid). | 11-20-2014 |
20150038837 | DEVICE FOR DETERMINING METASTASIS OF CANCER TO SENTINEL LYMPH NODE - Provided is a device capable of determining whether or not cancer has metastasized to a sentinel lymph node, such as the axillary lymph node, thickly covered with fat, safely and in a simple manner without confirmation by biopsy or extirpation. Fluorescence generated in a sentinel lymph node upon the excitation of protoporphyrin (a photosensitizing substance) derived from 5-ALA administered to a subject can be detected by passing a hollow tube, into which a small-diameter optical fiber for launching light and the small-diameter optical fiber for receiving light are inserted, through the lymph vessel to identify the presence or absence of the metastasis of cancer cells even before the surgery of cancer or during prognosis. | 02-05-2015 |